Related Experiment Videos
Metrizamide: a review with emphasis on drug interactions
American Journal of Hospital Pharmacy
|April 1, 1980
Summary
Metrizamide, a water-soluble contrast agent for myelography, has lower neurotoxicity due to its non-ionic nature. Careful drug selection is recommended to minimize seizure risk associated with this contrast medium.
Area of Science:
- Radiology
- Pharmacology
- Neurology
Background:
- Metrizamide is a water-soluble, non-ionic contrast medium utilized in myelography.
- Understanding its pharmacological profile, side effects, and drug interactions is crucial for patient safety.
Purpose of the Study:
- To review the pharmacology, side effects, and drug interactions of metrizamide.
- To assess the neurotoxicity and seizure risk associated with metrizamide administration.
Main Methods:
- Review of existing pharmacological data and clinical reports on metrizamide.
- Analysis of factors influencing metrizamide concentration in the brain and its excretion.
- Evaluation of reported side effects and drug interactions.
Main Results:
- Metrizamide exhibits lower neurotoxicity compared to other water-soluble contrast agents, attributed to its non-ionic nature.
- Common side effects like headache, nausea, and vomiting are comparable to other myelographic agents.
- Seizures, though rare, are linked to the dose and technique, emphasizing the importance of avoiding drugs that lower seizure threshold.
Conclusions:
- Metrizamide is a relatively safe contrast agent for myelography with manageable side effects.
- Caution is advised regarding concurrent use of medications that may lower seizure threshold.
- Further research on seizure prevention strategies is warranted.